Stephen M. Katz - Publications, H-index & Citations

Stephen M. Katz

university of texas system

23H指数

113论文数

2.0K被引数

收录论文 18

发表时间

ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function

CELL TRANSPLANTATION

IF3.2

2017-06-22

PREAI

Katz, SM; Bennett, F; Stecker, K; Clark, JH; Phan, T; Wang, M; Kahan, BD; Stepkowski, SM

C1Q POSITIVE ANTIBODIES IN PATIENTS WITH DONOR SPECIFIC HLA ANTIBODIES AND POST TRANSPLANT REJECTION

HUMAN IMMUNOLOGY

IF2.2

2011-10-01

PREAI

Saltarrelli, Jerome G.; Lappin, Jacqueline A.; Katz, Stephen M.; Varga, Karoly; Van Buren, Charles T.; Bihari, Laszlo A.; Cook, Daniel J.; Tyan, Dolly; Kerman, Ronald H.; Chen, Ge

THE RELEVANCE OF PRE-TRANSPLANT SOLUBLE HLA-G LEVELS AND/OR DONOR SPECIFIC HLA ANTIBODIES ON RENAL ALLOGRAFT SURVIVAL

HUMAN IMMUNOLOGY

IF2.2

2011-10-01

PREAI

Saltarrelli, Jerome G.; Bihari, Laszlo A.; Lappin, Jacqueline A.; Katz, Stephen M.; Varga, Karoly; Van Buren, Charles T.; Bentlejewski, Carol; Cook, Daniel J.; Zeevi, Adriana; Kerman, Ronald H.

Comparing an Early Corticosteroid/Late Calcineurin-Free Immunosuppression Protocol to a Sirolimus-, Cyclosporine A-, and Prednisone-Based Regimen for Pancreas-Kidney Transplantation

TRANSPLANTATION

IF5

2010-03-27

OAAI

Knight, Richard J.; Podder, Hemangshu; Kerman, Ronald H.; Lawless, Amy; Katz, Stephen M.; Van Buren, Charles T.; Gaber, A. Osama; Kahan, Barry D.

CONSEQUENCES OF ALLOCATING DECEASED DONOR ORGANS BASED ON RECIPENT ANTIBODY SPECIFICITIES

HUMAN IMMUNOLOGY

IF2.2

2008-10-01

PREAI

Kerman, Ronald H.; Van Buren, Charles T.; Katz, Stephen M.; Kahan, Barry D.; Lappin, Jacqueline; Olivarez, Carolyn; Shafer, Teresa

Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition

TRANSPLANTATION

IF5

2006-12-27

OAAI

Stepkowski, Stanislaw M.; Phan, Tammy; Zhang, Huimin; Bilinski, Szczepan; Kloc, Malgorzata; Qi, Yuhua; Katz, Stephen M.; Rutzky, Lynne P.

Clinical relevance of crossmatch results, HLA and non-HLA antibodies for renal allograft recipients

HUMAN IMMUNOLOGY

IF2.2

2006-10-01

PREAI

Kerman, Ronald H.; Stepkowski, Stanislaw M.; Knight, Richard M.; Katz, Stephen M.; McKissick, Eva; Young, Evelin; Acorda, Noriel; Hosek, Kathleen; Baron, Victor; Boatright, Michael; Hoover, Angela; Tu, Thuydung; Van Buren, Charles; Kahan, Barry

Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine

TRANSPLANTATION

IF5

2006-04-27

OAAI

Knight, RJ; Kerman, RH; Zela, S; Podbielski, J; Podder, H; Van Buren, CT; Katz, S; Kahan, BD

A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a US population of de novo renal transplant recipients

TRANSPLANTATION

IF5

2005-10-01

OAAI

Vincenti, F; Mendez, R; Curtis, J; Light, J; Pearson, T; Wu, YM; Katz, SM; Akalin, E; Esterl, R; Gugliuzza, K; Shihab, F; Jordan, S; Jonsson, J; Molmenti, E; Barbeito, R

Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients

TRANSPLANTATION

IF5

2005-09-27

121

OAAI

Kahan, BD; Yakupoglu, YK; Schoenberg, L; Knight, RJ; Katz, SM; Lai, D; Van Buren, CT

The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function

TRANSPLANTATION

IF5

2004-09-27

OAAI